Terms: = Lymphoma AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Treatment
51 results:
1. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
2. Mechanisms of theaflavins against gout and strategies for improving the bioavailability.
Chen J; Zheng Y; Gong S; Zheng Z; Hu J; Ma L; Li X; Yu H
Phytomedicine; 2023 Jun; 114():154782. PubMed ID: 36990009
[TBL] [Abstract] [Full Text] [Related]
3. Real-world utility of early measurable residual disease assessments by multi-parametric flow cytometry in adult patients with B-lymphoblastic leukemia receiving Hyper-CVAD induction chemotherapy.
Nedumannil R; Ritchie D; Bajel A; Ng AP; Harrison SJ; Westerman D
Eur J Haematol; 2023 Feb; 110(2):168-176. PubMed ID: 36321745
[TBL] [Abstract] [Full Text] [Related]
4. Prospective longitudinal evaluation of treatment-related toxicity and health-related quality of life during the first year of treatment for pediatric acute lymphoblastic leukemia.
Schilstra CE; McCleary K; Fardell JE; Donoghoe MW; McCormack E; Kotecha RS; Lourenco RA; Ramachandran S; Cockcroft R; Conyers R; Cross S; Dalla-Pozza L; Downie P; Revesz T; Osborn M; Alvaro F; Wakefield CE; Marshall GM; Mateos MK; Trahair TN
BMC Cancer; 2022 Sep; 22(1):985. PubMed ID: 36109702
[TBL] [Abstract] [Full Text] [Related]
5. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma.
Dlouhy I; Karube K; Enjuanes A; Salaverria I; Nadeu F; Ramis-Zaldivar JE; Valero JG; Rivas-Delgado A; Magnano L; Martin-García D; Pérez-Galán P; Clot G; Rovira J; Jares P; Balagué O; Giné E; Mozas P; Briones J; Sancho JM; Salar A; Mercadal S; Alcoceba M; Valera A; Campo E; López-Guillermo A
Br J Haematol; 2022 Feb; 196(3):589-598. PubMed ID: 34632572
[TBL] [Abstract] [Full Text] [Related]
6. Comparative Molecular Analysis of Primary Central Nervous System lymphomas and Matched Vitreoretinal lymphomas by Vitreous Liquid Biopsy.
Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
[TBL] [Abstract] [Full Text] [Related]
7. The long-term outcome and risk factors for precursor B cell acute lymphoblastic leukemia without specific fusion genes in Chinese children: experiences from multiple centers.
Zou P; Zhou M; Wen J; Liao X; Shen Y; Liu H; Song L; Xiao J
Bosn J Basic Med Sci; 2022 Apr; 22(2):238-246. PubMed ID: 34392828
[TBL] [Abstract] [Full Text] [Related]
8. A rapid genotyping panel for detection of primary central nervous system lymphoma.
Gupta M; Burns EJ; Georgantas NZ; Thierauf J; Nayyar N; Gordon A; Jones SS; Pisapia M; Sun Y; Burns RP; Velarde J; Jordan JT; Frigault MJ; Nahed BV; Jones PS; Barker FG; Curry WT; Gupta R; Batchelor TT; Romero JM; Brastianos PK; Marble HD; Martinez-Lage M; Tateishi K; Lennerz JK; Dietrich J; Cahill DP; Carter BS; Shankar GM
Blood; 2021 Aug; 138(5):382-386. PubMed ID: 33735913
[TBL] [Abstract] [Full Text] [Related]
9. Exploring htert promoter methylation in cutaneous T-cell lymphomas.
Chebly A; Ropio J; Peloponese JM; Poglio S; Prochazkova-Carlotti M; Cherrier F; Ferrer J; Idrissi Y; Segal-Bendirdjian E; Chouery E; Farra C; Pham-Ledard A; Beylot-Barry M; Merlio JP; Tomb R; Chevret E
Mol Oncol; 2022 May; 16(9):1931-1946. PubMed ID: 33715271
[TBL] [Abstract] [Full Text] [Related]
10. Giant congenital nodular melanoma in a newborn: a case report and literature review.
Zhou J; Lv MX; Duan L; Xie YC; A ZX; Wu HF; Gao Y
BMC Pediatr; 2021 Mar; 21(1):121. PubMed ID: 33706747
[TBL] [Abstract] [Full Text] [Related]
11. A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.
Benslimane Y; Sánchez-Osuna M; Coulombe-Huntington J; Bertomeu T; Henry D; Huard C; Bonneil É; Thibault P; Tyers M; Harrington L
Aging Cell; 2021 Apr; 20(4):e13331. PubMed ID: 33660365
[TBL] [Abstract] [Full Text] [Related]
12. Biological categories of neuroblastoma based on the international neuroblastoma pathology classification for treatment stratification.
Nakazawa A
Pathol Int; 2021 Apr; 71(4):232-244. PubMed ID: 33657257
[TBL] [Abstract] [Full Text] [Related]
13. Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma.
Bu L; Hameed NUF; Luo C; Hong P; Zhou X; Wang S; Wu S
J Neurooncol; 2021 Mar; 152(1):27-36. PubMed ID: 33486679
[TBL] [Abstract] [Full Text] [Related]
14. Combination Strategies to Improve Targeted Radionuclide Therapy.
Chan TG; O'Neill E; Habjan C; Cornelissen B
J Nucl Med; 2020 Nov; 61(11):1544-1552. PubMed ID: 33037092
[TBL] [Abstract] [Full Text] [Related]
15. Prevalence and potential biological role of tert amplifications in ALK translocated adenocarcinoma of the lung.
Alidousty C; Duerbaum N; Wagener-Ryczek S; Baar T; Martelotto LG; Heydt C; Siemanowski J; Holz B; Binot E; Fassunke J; Merkelbach-Bruse S; Wolf J; Kron A; Buettner R; Schultheis AM
Histopathology; 2021 Mar; 78(4):578-585. PubMed ID: 32946634
[TBL] [Abstract] [Full Text] [Related]
16.
Bhagat M; Kumar A; Suravajhala R
Curr Top Med Chem; 2020; 20(22):1981-1992. PubMed ID: 32703136
[TBL] [Abstract] [Full Text] [Related]
17. Association of
Kodidela S; Dorababu P; Thakkar DN; Dubashi B; Sundaram R; Muralidharan N; Nidanapu RP; Aribandi A; Pradhan SC; Uppugunduri CRS
Genes (Basel); 2020 May; 11(6):. PubMed ID: 32481505
[TBL] [Abstract] [Full Text] [Related]
18. Clinical characterization and prognosis of T cell acute lymphoblastic leukemia with high CRLF2 gene expression in children.
Wang M; Wen J; Guo Y; Shen Y; An X; Hu Y; Xiao J
PLoS One; 2019; 14(12):e0224652. PubMed ID: 31830053
[TBL] [Abstract] [Full Text] [Related]
19. Severe therapy-related toxicities after treatment for Hodgkin lymphoma due to a pathogenic tert variant and shortened telomeres.
Agrusa JE; Bertuch AA; DiNardo CD; Plon SE; Eckstein OS
Pediatr Blood Cancer; 2019 Aug; 66(8):e27779. PubMed ID: 31050187
[TBL] [Abstract] [Full Text] [Related]
20.
Hernandez R; Walker KL; Grudzinski JJ; Aluicio-Sarduy E; Patel R; Zahm CD; Pinchuk AN; Massey CF; Bitton AN; Brown RJ; Sondel PM; Morris ZS; Engle JW; Capitini CM; Weichert JP
Commun Biol; 2019; 2():79. PubMed ID: 30820474
[TBL] [Abstract] [Full Text] [Related]
[Next]
